The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
The Intermountain Healthcare Supply Chain Organization has embarked on strategy to drive costs out of the healthcare supply chain. As a part of that…
On-Demand Educational Webinars
The supply chain ecosystem has contributed to the 25% waste in the health care system. We can accept that reality while at the same time learning to…
Podcasts
As UDI capture and exchange becomes more prevalent across the healthcare ecosystem and as implantable device information is linked to patient outco
Webcast
Panelists in Part 4 of the GPO or Local/Self Contracting webcast series focus on what providers should expect from their GPO partners. In a Part 5…